We are live on ! Find out more
IART icon

Integra LifeSciences
IART

280 hedge funds and large institutions have $4.16B invested in Integra LifeSciences in 2019 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 100 increasing their positions, 88 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 23

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

29% more call options, than puts

Call options by funds: $5.85M | Put options by funds: $4.52M

14% more repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 88

7% more funds holding

Funds holding: 262 → 280 (+18)

5% more capital invested

Capital invested by funds: $3.95B → $4.16B (+$210M)

1.8% less ownership

Funds ownership: 82.73% → 80.93% (-1.8%)

Holders
280
Holders Change
+18
Holders Change %
+6.87%
% of All Funds
6.14%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
42
Increased
100
Reduced
88
Closed
23
Calls
$5.85M
Puts
$4.52M
Net Calls
+$1.33M
Net Calls Change
+$1.21M

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$23.5M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$22.1M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$21.1M
4
Brown Advisory
Brown Advisory
Maryland
+$13.9M
5
Millennium Management
Millennium Management
New York
+$12.6M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$98.7M
2
Capital World Investors
Capital World Investors
California
-$63.5M
3
Capital International Investors
Capital International Investors
California
-$27.3M
4
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$16.4M
5
State Street
State Street
Massachusetts
-$14.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
LCM
201
Laurion Capital Management
New York
$319K +$317K +5,313 New
Baird Financial Group
202
Baird Financial Group
Wisconsin
$318K +$29.2K +490 +10%
SO
203
STRS Ohio
Ohio
$313K +$311K +5,219 New
CSS
204
Cubist Systematic Strategies
Connecticut
$311K -$805K -13,518 -72%
LIA
205
LS Investment Advisors
Michigan
$310K +$7.09K +119 +2%
CCA
206
Conestoga Capital Advisors
Pennsylvania
$300K – – –
C
207
Cerebellum
California
$297K +$295K +4,946 New
PTC
208
Petrus Trust Company
Texas
$296K +$1.37K +23 +0.5%
RCM
209
Riverhead Capital Management
Delaware
$290K – – –
SCM
210
Shelton Capital Management
Colorado
$284K -$19.4K -325 -6%
FIM
211
Freedom Investment Management
Connecticut
$276K +$273K +4,587 New
Zurich Cantonal Bank
212
Zurich Cantonal Bank
Switzerland
$275K +$21.4K +360 +9%
BC
213
Burney Company
Virginia
$267K +$2.38K +40 +0.9%
JMPWA
214
JP Morgan Private Wealth Advisors
California
$267K +$21.9K +367 +9%
NIC
215
Northwest Investment Counselors
Oregon
$263K – – –
ZB
216
Zions Bancorporation
Utah
$263K +$1.07K +18 +0.4%
MOS
217
MGO One Seven
Ohio
$255K +$238 +4 +0.1%
SLG
218
Stanley-Laman Group
Pennsylvania
$240K – – –
ECM
219
ExodusPoint Capital Management
New York
$238K +$236K +3,968 New
AWM
220
Alterna Wealth Management
Texas
$216K -$5.36K -90 -2%
Allianz Asset Management
221
Allianz Asset Management
Germany
$212K +$210K +3,524 New
QT
222
Quantbot Technologies
New York
$203K +$184K +3,080 +1,027%
JG
223
Jefferies Group
New York
$203K +$201K +3,380 New
Barclays
224
Barclays
United Kingdom
$201K -$4.7M -78,956 -96%
WT
225
Whittier Trust
California
$201K – – –
7 8
9
10 11

IART Hedge Fund Activity: Q3 2019 in Review

280 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q3 2019, worth a combined $4.16B — up 5.3% from $3.95B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new IART positions and 23 closed out — a net gain of 19 holders — while 100 added to existing stakes and 88 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $23.5M. The largest seller was Fidelity Investments, cutting an estimated $98.7M.

  • 280 institutional investors held Integra LifeSciences (IART) as of Q3 2019, up from 262 in Q2 2019.
  • Funds reported $4.16B of Integra LifeSciences stock for Q3 2019, up 5.3% quarter-over-quarter.
  • 42 funds opened new Integra LifeSciences positions in Q3 2019 and 23 closed out, a net change of +19 holders.
  • The largest Integra LifeSciences buyer in Q3 2019 was Point72 Asset Management, an estimated $23.5M added.
  • The largest Integra LifeSciences seller in Q3 2019 was Fidelity Investments, an estimated $98.7M sold.

Based on aggregated 13F filings for Q3 2019.